Management of tegmen defects with mastoid and epitympanic obliteration using S53P4 bioactive glass

摘要

To evaluate the surgical results and complications in a cohort of patients operated on to repair a tegmen bony defect using either transmastoid approach with obliteration using S53P4 bioactive glass granules (TMA‐O), or the classic middle cranial fossa approach (MCFA).